Prospective multicentre observational study of lymphedema therapy: POLIT study.
Identifieur interne : 001487 ( PubMed/Corpus ); précédent : 001486; suivant : 001488Prospective multicentre observational study of lymphedema therapy: POLIT study.
Auteurs : I. Quéré ; E. Presles ; M. Coupé ; S. Vignes ; L. Vaillant ; D. Eveno ; S. Laporte ; A. LeizoroviczSource :
- Journal des maladies vasculaires [ 2214-8116 ] ; 2014.
English descriptors
- KwdEn :
- Adult, Aged, Arm (pathology), Breast Neoplasms (surgery), Compression Bandages (adverse effects), Exercise Therapy, Female, Follow-Up Studies, Humans, Leg (pathology), Lymph Node Excision (adverse effects), Lymphedema (etiology), Lymphedema (pathology), Lymphedema (rehabilitation), Lymphedema (therapy), Massage, Middle Aged, Organ Size, Prospective Studies, Treatment Outcome.
- MESH :
- adverse effects : Compression Bandages, Lymph Node Excision.
- etiology : Lymphedema.
- pathology : Arm, Leg, Lymphedema.
- rehabilitation : Lymphedema.
- surgery : Breast Neoplasms.
- therapy : Lymphedema.
- Adult, Aged, Exercise Therapy, Female, Follow-Up Studies, Humans, Massage, Middle Aged, Organ Size, Prospective Studies, Treatment Outcome.
Abstract
Lymphedema treatment is based on Decongestive Lymphedema Therapy (DLT) with an intensive phase followed by a long-term maintenance phase. This study aimed to observe volume variation over the intensive phase and 6 months later.
DOI: 10.1016/j.jmv.2014.05.004
PubMed: 24931830
Links to Exploration step
pubmed:24931830Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prospective multicentre observational study of lymphedema therapy: POLIT study.</title><author><name sortKey="Quere, I" sort="Quere, I" uniqKey="Quere I" first="I" last="Quéré">I. Quéré</name><affiliation><nlm:affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France. Electronic address: i-quere@chu-montpellier.fr.</nlm:affiliation></affiliation></author><author><name sortKey="Presles, E" sort="Presles, E" uniqKey="Presles E" first="E" last="Presles">E. Presles</name><affiliation><nlm:affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France.</nlm:affiliation></affiliation></author><author><name sortKey="Coupe, M" sort="Coupe, M" uniqKey="Coupe M" first="M" last="Coupé">M. Coupé</name><affiliation><nlm:affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name><affiliation><nlm:affiliation>Department of Lymphology, Cognacq-Jay Hospital, 75015 Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vaillant, L" sort="Vaillant, L" uniqKey="Vaillant L" first="L" last="Vaillant">L. Vaillant</name><affiliation><nlm:affiliation>Université François-Rabelais, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France.</nlm:affiliation></affiliation></author><author><name sortKey="Eveno, D" sort="Eveno, D" uniqKey="Eveno D" first="D" last="Eveno">D. Eveno</name><affiliation><nlm:affiliation>Service de médecine interne, Hôtel-Dieu, 44093 Nantes cedex 01, France.</nlm:affiliation></affiliation></author><author><name sortKey="Laporte, S" sort="Laporte, S" uniqKey="Laporte S" first="S" last="Laporte">S. Laporte</name><affiliation><nlm:affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France; EA 3065, université Jean-Monnet, 42023 Saint-Étienne, France.</nlm:affiliation></affiliation></author><author><name sortKey="Leizorovicz, A" sort="Leizorovicz, A" uniqKey="Leizorovicz A" first="A" last="Leizorovicz">A. Leizorovicz</name><affiliation><nlm:affiliation>UMR 5558, CNRS Villeurbanne, université Claude-Bernard - Lyon 1, 69373 Lyon cedex 08, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24931830</idno><idno type="pmid">24931830</idno><idno type="doi">10.1016/j.jmv.2014.05.004</idno><idno type="wicri:Area/PubMed/Corpus">001487</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001487</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prospective multicentre observational study of lymphedema therapy: POLIT study.</title><author><name sortKey="Quere, I" sort="Quere, I" uniqKey="Quere I" first="I" last="Quéré">I. Quéré</name><affiliation><nlm:affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France. Electronic address: i-quere@chu-montpellier.fr.</nlm:affiliation></affiliation></author><author><name sortKey="Presles, E" sort="Presles, E" uniqKey="Presles E" first="E" last="Presles">E. Presles</name><affiliation><nlm:affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France.</nlm:affiliation></affiliation></author><author><name sortKey="Coupe, M" sort="Coupe, M" uniqKey="Coupe M" first="M" last="Coupé">M. Coupé</name><affiliation><nlm:affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vignes, S" sort="Vignes, S" uniqKey="Vignes S" first="S" last="Vignes">S. Vignes</name><affiliation><nlm:affiliation>Department of Lymphology, Cognacq-Jay Hospital, 75015 Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vaillant, L" sort="Vaillant, L" uniqKey="Vaillant L" first="L" last="Vaillant">L. Vaillant</name><affiliation><nlm:affiliation>Université François-Rabelais, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France.</nlm:affiliation></affiliation></author><author><name sortKey="Eveno, D" sort="Eveno, D" uniqKey="Eveno D" first="D" last="Eveno">D. Eveno</name><affiliation><nlm:affiliation>Service de médecine interne, Hôtel-Dieu, 44093 Nantes cedex 01, France.</nlm:affiliation></affiliation></author><author><name sortKey="Laporte, S" sort="Laporte, S" uniqKey="Laporte S" first="S" last="Laporte">S. Laporte</name><affiliation><nlm:affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France; EA 3065, université Jean-Monnet, 42023 Saint-Étienne, France.</nlm:affiliation></affiliation></author><author><name sortKey="Leizorovicz, A" sort="Leizorovicz, A" uniqKey="Leizorovicz A" first="A" last="Leizorovicz">A. Leizorovicz</name><affiliation><nlm:affiliation>UMR 5558, CNRS Villeurbanne, université Claude-Bernard - Lyon 1, 69373 Lyon cedex 08, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal des maladies vasculaires</title><idno type="eISSN">2214-8116</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Arm (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Compression Bandages (adverse effects)</term><term>Exercise Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Leg (pathology)</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphedema (etiology)</term><term>Lymphedema (pathology)</term><term>Lymphedema (rehabilitation)</term><term>Lymphedema (therapy)</term><term>Massage</term><term>Middle Aged</term><term>Organ Size</term><term>Prospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Compression Bandages</term><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arm</term><term>Leg</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Exercise Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Massage</term><term>Middle Aged</term><term>Organ Size</term><term>Prospective Studies</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphedema treatment is based on Decongestive Lymphedema Therapy (DLT) with an intensive phase followed by a long-term maintenance phase. This study aimed to observe volume variation over the intensive phase and 6 months later.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24931830</PMID><DateCreated><Year>2014</Year><Month>07</Month><Day>22</Day></DateCreated><DateCompleted><Year>2016</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2014</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2214-8116</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal des maladies vasculaires</Title><ISOAbbreviation>J Mal Vasc</ISOAbbreviation></Journal><ArticleTitle>Prospective multicentre observational study of lymphedema therapy: POLIT study.</ArticleTitle><Pagination><MedlinePgn>256-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmv.2014.05.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0398-0499(14)00094-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Lymphedema treatment is based on Decongestive Lymphedema Therapy (DLT) with an intensive phase followed by a long-term maintenance phase. This study aimed to observe volume variation over the intensive phase and 6 months later.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Prospective multicentre observational study of patients with unilateral lymphedema. The primary objective was to assess lymphedema volume variation between baseline, the end of intensive phase and 6 months later. Secondary objectives were to assess the frequency of heaviness limiting limb function and treatments safety predictors for volume reduction.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three hundred and six patients (89.9% women; 59.9±14.3 years old) with upper/lower (n=184/122) limb lymphedema were included. At the end of the intensive phase, median excess lymphedema volume reduction was 31.0% (41.7-19.9) followed by a 16.5% (5.9-42.3) median increase over the 6-month maintenance period phase. Previous intensive treatment was the only significant predictor of this response. As compared to baseline, heaviness limiting limb use was much less frequently reported at the end of the reductive phase (75.5% versus 42.3% respectively), and was more frequent at the end of the maintenance phase (62.6%). The most frequent adverse events reported were skin redness and compression marks (18.4 and 15.7% of patients, respectively). Blisters requiring treatment stoppage were rare (1.4%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intensive phase decreases lymphedema volume and heaviness limiting limb function. The benefit is partially abolished after the first 6 months of maintenance. There is a need to consider how to provide optimal patient care for the long-term control of lymphedema.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quéré</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France. Electronic address: i-quere@chu-montpellier.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Presles</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coupé</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>EA 2992, Vascular Medicine Unit, CIC1001 Inserm, CHU de Montpellier, université Montpellier 1, 34295 cedex 5 Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vignes</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Lymphology, Cognacq-Jay Hospital, 75015 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaillant</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Université François-Rabelais, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eveno</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service de médecine interne, Hôtel-Dieu, 44093 Nantes cedex 01, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laporte</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Inserm, CIE3, unité de recherche clinique, innovation et pharmacologie, CHU de Saint-Étienne, 42055 Saint-Étienne, France; EA 3065, université Jean-Monnet, 42023 Saint-Étienne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leizorovicz</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UMR 5558, CNRS Villeurbanne, université Claude-Bernard - Lyon 1, 69373 Lyon cedex 08, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>POLIT Study investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>J Mal Vasc</MedlineTA><NlmUniqueID>7707965</NlmUniqueID><ISSNLinking>0398-0499</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058128" MajorTopicYN="Y">Compression Bandages</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005081" MajorTopicYN="Y">Exercise Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008405" MajorTopicYN="Y">Massage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bandage</Keyword><Keyword MajorTopicYN="N">Bandaging</Keyword><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">Compression</Keyword><Keyword MajorTopicYN="N">Decongestive therapy</Keyword><Keyword MajorTopicYN="N">Lymphedema</Keyword><Keyword MajorTopicYN="N">Lymphœdème</Keyword><Keyword MajorTopicYN="N">Traitement décongestif</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>05</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24931830</ArticleId><ArticleId IdType="pii">S0398-0499(14)00094-8</ArticleId><ArticleId IdType="doi">10.1016/j.jmv.2014.05.004</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001487 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001487 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24931830
|texte= Prospective multicentre observational study of lymphedema therapy: POLIT study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24931830" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |